Clinical Trial

Published on 07 Apr 2021

Levoketoconazole in the Treatment of Patients With Cushing’s Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study

in Pituitary Endocrinology

Rosario Pivonello
Atanaska Elenkova
Maria Fleseriu
Richard A. Feelders
Przemyslaw Witek
Yona Greenman
Eliza B. Geer
Paola Perotti
Leonard Saiegh
Fredric Cohen

Frontiers in Endocrinology

doi 10.3389/fendo.2021.595894

9,574 views
21 citations

Review

Published on 26 Mar 2021

Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors

in Pituitary Endocrinology

Tae Nakano-Tateno
Kheng Joe Lau
Justin Wang
Cailin McMahon
Yasuhiko Kawakami
Toru Tateno
Takako Araki

Frontiers in Endocrinology

doi 10.3389/fendo.2021.624686

6,615 views
19 citations

Case Report

Published on 22 Mar 2021

Case Report: A Case of Pituitary Adenoma Producing Growth Hormone and Thyroid-Stimulating Hormone Simultaneously

in Pituitary Endocrinology

Junpei Sanada
Fuminori Tatsumi
Shinji Kamei
Yoshiro Fushimi
Masashi Shimoda
Kenji Kohara
Shuhei Nakanishi
Kohei Kaku
Tomoatsu Mune
Hideaki Kaneto

Frontiers in Endocrinology

doi 10.3389/fendo.2021.659076

12,873 views
2 citations

Original Research

Published on 18 Mar 2021

Significance of Crooke's Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing Disease

in Pituitary Endocrinology

Amit Akirov
Vincent Larouche
Ilan Shimon
Sylvia L. Asa
Ozgur Mete
Anna M. Sawka
Fred Gentili
Shereen Ezzat

Frontiers in Endocrinology

doi 10.3389/fendo.2021.620005

6,872 views
7 citations

Mini Review

Published on 17 Mar 2021

How to Classify and Define Pituitary Tumors: Recent Advances and Current Controversies

in Pituitary Endocrinology

Congxin Dai
Jun Kang
Xiaohai Liu
Yong Yao
Haijun Wang
Renzhi Wang

Frontiers in Endocrinology

doi 10.3389/fendo.2021.604644

12,389 views
27 citations

Original Research

Published on 16 Mar 2021

Complications and Comorbidities of Acromegaly—Retrospective Study in Polish Center

in Pituitary Endocrinology

Małgorzata Rolla
Aleksandra Jawiarczyk-Przybyłowska
Jowita Halupczok-Żyła
Marcin Kałużny
Bogumil M. Konopka
Izabela Błoniecka
Grzegorz Zieliński
Marek Bolanowski

Frontiers in Endocrinology

doi 10.3389/fendo.2021.642131

5,863 views
21 citations

Review

Published on 16 Mar 2021

Pasireotide in the Personalized Treatment of Acromegaly

in Pituitary Endocrinology

Manel Puig-Domingo
Ignacio Bernabéu
Antonio Picó
Betina Biagetti
Joan Gil
Cristina Alvarez-Escolá
Mireia Jordà
Montserrat Marques-Pamies
Berta Soldevila
María-Angeles Gálvez

Frontiers in Endocrinology

doi 10.3389/fendo.2021.648411

10,139 views
31 citations

Mini Review

Published on 15 Mar 2021

Epithelial–Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly

in Pituitary Endocrinology

Joan Gil
Mireia Jordà
Berta Soldevila
Manel Puig-Domingo

Frontiers in Endocrinology

doi 10.3389/fendo.2021.646210

3,613 views
18 citations

Review

Published on 15 Mar 2021

Traumatic Brain Injury as Frequent Cause of Hypopituitarism and Growth Hormone Deficiency: Epidemiology, Diagnosis, and Treatment

in Pituitary Endocrinology

Valentina Gasco
Valeria Cambria
Fabio Bioletto
Ezio Ghigo
Silvia Grottoli

Frontiers in Endocrinology

doi 10.3389/fendo.2021.634415

18,534 views
39 citations

Original Research

Published on 15 Mar 2021

Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands

in Pituitary Endocrinology

Maria Fleseriu
Mark Molitch
Alexander Dreval
Nienke R. Biermasz
Murray B. Gordon
Ross D. Crosby
William H. Ludlam
Asi Haviv
Yossi Gilgun-Sherki
Susan D. Mathias

Frontiers in Endocrinology

doi 10.3389/fendo.2021.627711

5,002 views
24 citations

Case Report

Published on 12 Mar 2021

Case Report: Temozolomide Treatment of Refractory Prolactinoma Resistant to Dopamine Agonists

in Pituitary Endocrinology

Hao Tang
Yijun Cheng
Jinyan Huang
Jianfeng Li
Benyan Zhang
Zhe Bao Wu

Frontiers in Endocrinology

doi 10.3389/fendo.2021.616339

4,177 views
11 citations

Review

Published on 12 Mar 2021

Pituitary Disorders and COVID-19, Reimagining Care: The Pandemic A Year and Counting

in Pituitary Endocrinology

Maria Fleseriu

Frontiers in Endocrinology

doi 10.3389/fendo.2021.656025

21,956 views
12 citations

Case Report

Published on 11 Mar 2021

Case Report and Literature Review: Ectopic Thyrotropin-Secreting Pituitary Adenoma in the Suprasellar Region

in Pituitary Endocrinology

Xiaoxu Li
Binghao Zhao
Bo Hou
Jing Wang
Jianyu Zhu
Yong Yao
Xiaolan Lian

Frontiers in Endocrinology

doi 10.3389/fendo.2021.619161

4,494 views
12 citations

Systematic Review

Published on 11 Mar 2021

The Complex World of Regulation of Pituitary Growth Hormone Secretion: The Role of Ghrelin, Klotho, and Nesfatins in It

in Pituitary Endocrinology

Jesús Devesa

Frontiers in Endocrinology

doi 10.3389/fendo.2021.636403

13,881 views
31 citations

Original Research

Published on 10 Mar 2021

The Effect of 6 Months’ Treatment With Pasireotide LAR on Glucose Metabolism in Patients With Resistant Acromegaly in Real-World Clinical Settings

in Pituitary Endocrinology

Przemysław Witek
Marek Bolanowski
Katarzyna Szamotulska
Agnieszka Wojciechowska-Luźniak
Aleksandra Jawiarczyk-Przybyłowska
Marcin Kałużny

Frontiers in Endocrinology

doi 10.3389/fendo.2021.633944

3,159 views
15 citations

Original Research

Published on 02 Mar 2021

Machine Learning in Preoperative Prediction of Postoperative Immediate Remission of Histology-Positive Cushing’s Disease

in Pituitary Endocrinology

Wentai Zhang
Mengke Sun
Yanghua Fan
He Wang
Ming Feng
Shaohua Zhou
Renzhi Wang

Frontiers in Endocrinology

doi 10.3389/fendo.2021.635795

2,906 views
14 citations

Navigation group

Articles

Levoketoconazole in the Treatment of Patients With Cushing’s Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study

Multimodal Non-Surgical Treatments of Aggressive Pituitary Tumors

Case Report: A Case of Pituitary Adenoma Producing Growth Hormone and Thyroid-Stimulating Hormone Simultaneously

Significance of Crooke's Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing Disease

How to Classify and Define Pituitary Tumors: Recent Advances and Current Controversies

Complications and Comorbidities of Acromegaly—Retrospective Study in Polish Center

Pasireotide in the Personalized Treatment of Acromegaly

Epithelial–Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly

Traumatic Brain Injury as Frequent Cause of Hypopituitarism and Growth Hormone Deficiency: Epidemiology, Diagnosis, and Treatment

Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands

Case Report: Temozolomide Treatment of Refractory Prolactinoma Resistant to Dopamine Agonists

Pituitary Disorders and COVID-19, Reimagining Care: The Pandemic A Year and Counting

Case Report and Literature Review: Ectopic Thyrotropin-Secreting Pituitary Adenoma in the Suprasellar Region

The Complex World of Regulation of Pituitary Growth Hormone Secretion: The Role of Ghrelin, Klotho, and Nesfatins in It

The Effect of 6 Months’ Treatment With Pasireotide LAR on Glucose Metabolism in Patients With Resistant Acromegaly in Real-World Clinical Settings

Machine Learning in Preoperative Prediction of Postoperative Immediate Remission of Histology-Positive Cushing’s Disease